The primary aim of this clinical study is to determine the impact of ACE inhibitors, β-blockers and other potential risk factors such as the patient’s pelvic and anatomical characteristics on ART emergence in patients with locally advanced cervical cancer treated by chemoradiotherapy. This evidence concerns the gene ACE and cervical carcinoma.